| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.066 | 0.09 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.08 | 0.09 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.051 | 0.09 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.09 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.048 | 0.09 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.09 |